reciprocal electrical stimulation
OtherMode (A) is selected to apply reciprocal neuromuscular electrical stimulation
Other names: Everyway-EV906
NCT Number: NCT07599267
to investigate the effect of the reciprocal neuromuscular electrical stimulation on balance and quality of life in hemiparetic children
Trial opening soon.
Get Notified6 year–10 year
All sexes
Interventional
Not applicable
Neuromuscular Electrical Stimulation is widely used to reduce spasticity and strengthen weak muscles.
Reciprocal electrical stimulation ( RES),which mimic natural agonist-antagonist muscle activation , is a promising too for neuromuscular re-education.
RES has been studied for knee stability in diplegic CP and ankle control in adults but its effect on static and dynamic balance in hemiparetic CP remain unexplored . so this study may be a guide in management of balance problems in children with hemiparesis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mode (A) is selected to apply reciprocal neuromuscular electrical stimulation
Other names: Everyway-EV906
Other names: designed physical therapy program
Time frame: 3 monthes
the ability to maintain a stable posture and preserve it in counter gravity position
Time frame: 3 months
change in social, psychological and physical domains
Cairo University
Other
Effect of Reciprocal Neuromuscular Electrical Stimulation on Balance and Quality of Life in Children With Hemiparesis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05349136
Brain Damage, Chronic, Brain Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT00991692
Brain Damage, Chronic, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06438666
Brain Damage, Chronic, Brain Diseases
Málaga, Spain
View Trial DetailsNCT07269353
Brain Damage, Chronic, Brain Diseases
Edmonton, Alberta, Canada
View Trial Details